NCT06405490
- Conditions
- Advanced Cancer, Cadonilimab, Capecitabine, +5 more
- Locations
-
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
Clinical trial condition
Explore clinical trials studying Drug Use. Study availability and eligibility vary by location and protocol.
NCT06405490
NCT03671629
NCT06498167
NCT07508137
NCT06331767
Not specified
NCT04935606
NCT05609864
NCT05553054
NCT04804072
NCT04677114